Casey Woodring
Stock Analyst at JP Morgan
(0.79)
# 4,038
Out of 5,127 analysts
61
Total ratings
22.86%
Success rate
-12.96%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IQV IQVIA Holdings | Maintains: Overweight | $255 → $225 | $182.45 | +23.32% | 2 | Feb 6, 2026 | |
| ILMN Illumina | Maintains: Neutral | $130 → $120 | $119.32 | +0.57% | 3 | Feb 6, 2026 | |
| QGEN Qiagen | Maintains: Overweight | $55 → $60 | $51.08 | +17.46% | 5 | Feb 6, 2026 | |
| TEM Tempus AI | Maintains: Neutral | $85 → $80 | $55.88 | +43.16% | 1 | Dec 15, 2025 | |
| NTRA Natera | Maintains: Overweight | $250 → $260 | $211.65 | +22.84% | 3 | Dec 15, 2025 | |
| GH Guardant Health | Maintains: Overweight | $90 → $120 | $105.01 | +14.27% | 2 | Dec 15, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $165 → $190 | $181.24 | +4.83% | 10 | Dec 15, 2025 | |
| BRKR Bruker | Maintains: Overweight | $50 → $55 | $41.58 | +32.28% | 1 | Dec 15, 2025 | |
| BLLN BillionToOne | Maintains: Overweight | $150 → $145 | $91.94 | +57.71% | 2 | Dec 10, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $165 → $180 | $129.00 | +39.53% | 2 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $26 → $22 | $29.21 | -24.68% | 5 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $19.15 | -21.67% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $16 | $17.46 | -8.36% | 3 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $12 | $11.16 | +7.53% | 1 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $78 | $75.15 | +3.79% | 6 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $325 | $327.02 | -0.62% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $600 → $650 | $539.80 | +20.41% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1,200 → $1,285 | $1,400.33 | -8.24% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $265 → $150 | $144.55 | +3.77% | 6 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $2.81 | +113.52% | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $23 | $26.79 | -14.15% | 2 | Oct 31, 2023 |
IQVIA Holdings
Feb 6, 2026
Maintains: Overweight
Price Target: $255 → $225
Current: $182.45
Upside: +23.32%
Illumina
Feb 6, 2026
Maintains: Neutral
Price Target: $130 → $120
Current: $119.32
Upside: +0.57%
Qiagen
Feb 6, 2026
Maintains: Overweight
Price Target: $55 → $60
Current: $51.08
Upside: +17.46%
Tempus AI
Dec 15, 2025
Maintains: Neutral
Price Target: $85 → $80
Current: $55.88
Upside: +43.16%
Natera
Dec 15, 2025
Maintains: Overweight
Price Target: $250 → $260
Current: $211.65
Upside: +22.84%
Guardant Health
Dec 15, 2025
Maintains: Overweight
Price Target: $90 → $120
Current: $105.01
Upside: +14.27%
Charles River Laboratories International
Dec 15, 2025
Maintains: Neutral
Price Target: $165 → $190
Current: $181.24
Upside: +4.83%
Bruker
Dec 15, 2025
Maintains: Overweight
Price Target: $50 → $55
Current: $41.58
Upside: +32.28%
BillionToOne
Dec 10, 2025
Maintains: Overweight
Price Target: $150 → $145
Current: $91.94
Upside: +57.71%
Agilent Technologies
Nov 25, 2025
Maintains: Overweight
Price Target: $165 → $180
Current: $129.00
Upside: +39.53%
Nov 7, 2025
Maintains: Underweight
Price Target: $26 → $22
Current: $29.21
Upside: -24.68%
Nov 7, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $19.15
Upside: -21.67%
Nov 5, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $17.46
Upside: -8.36%
Oct 30, 2025
Downgrades: Neutral
Price Target: $14 → $12
Current: $11.16
Upside: +7.53%
Oct 22, 2025
Downgrades: Neutral
Price Target: $78
Current: $75.15
Upside: +3.79%
Oct 9, 2025
Maintains: Neutral
Price Target: $300 → $325
Current: $327.02
Upside: -0.62%
Oct 9, 2025
Maintains: Overweight
Price Target: $600 → $650
Current: $539.80
Upside: +20.41%
Oct 9, 2025
Maintains: Neutral
Price Target: $1,200 → $1,285
Current: $1,400.33
Upside: -8.24%
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $144.55
Upside: +3.77%
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $2.81
Upside: +113.52%
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $26.79
Upside: -14.15%